Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, on January 27, 2020 declared the Company will be showcasing the modern advancements to its medication management portfolio at the Arab Health Exhibition and Congress from 27-30 January in Dubai. Arab Health is the biggest gathering of healthcare and trade experts in the Middle East region.
According to a report by Colliers International, healthcare spending in Saudi Arabia alone has grown at a compound annual growth rate of 12.1 percentage over the previous nine years, and is expected to increase to US$160 billion by 2030. Omnicell’s solution portfolio helps the vision of autonomous pharmacy, a roadmap designed to enhance patient results and operational efficiencies while assisting to reduce cost via a sequence of autonomous and digital workflows, powered by a cloud data platform.
The autonomous pharmacy vision integrates solutions throughout three key areas. These will be showcased in Hall 3, Stand J30 at the time of the Exhibition and Congress:
Automation– progressive solutions designed to digitize and streamline workflows throughout the continuum of care. Omnicell’s platform of automation solutions helps medication safety on patient wards; offers more efficient medication storage, dispensing, and filling in the hospital pharmacy; and helps enhance medication adherence via automated multimed packaging solutions for outpatient pharmacy, which can result in better patient outcomes.
Intelligence– predictive intelligence that offers actionable insights to better apprehend medication utilization and improve pharmacy supply chain management. Omnicell solutions provide flexibility to manipulate supplies anywhere in the hospital via better tracking, utilization capture and visibility to assist minimize stock outs or over-ordering inventory.
Expert Services– an extension of pharmacy operations to assist elevated efficiency and better patient care. These services can assist deliver an accelerated time-to-value for implementation projects and greater achievement of anticipated outcomes.
“At Omnicell, we recognize the risk and cost associated with manual, inefficient processes,” stated Arthur Van Dongen, vice president and general manager, International at Omnicell. “We are dedicated to delivering the technology and equipment that will automate these processes, ultimately assisting our hospital partners achieve their operational, financial, and medical outcomes.”